Brain Tumor Treatment Satisfaction Survey

This study is currently recruiting participants.

Verified by Methodist Healthcare, February 2009

First Received: November 13, 2007 Last Updated: February 3, 2009 History of Changes

Sponsored by:	Methodist Healthcare
Information provided by:	Methodist Healthcare
ClinicalTrials.gov Identifier:	NCT00557375

Purpose

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Condition
Brain Tumors

MedlinePlus related topics: Brain Cancer Cancer Caregivers

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Cross-Sectional
Official Title:	Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers

Further study details as provided by Methodist Healthcare:

Primary Outcome Measures:

Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors. [ Time Frame: (greater than or equal to 3 months) from first treatment for brain tumor ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver. [ Time Frame: (Greater than or equal to 3 months) from first treatment for brain tumor ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	700
Study Start Date:	June 2007
Estimated Study Completion Date:	November 2009

Groups/Cohorts
1 Brain tumor patients
2 Caregivers of brain tumor patients

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Brain tumor patients and their caregivers

Criteria

Inclusion Criteria:

Patients who are between 3 months and one year out from treatment for their brain tumor
Karnofsky Performance Status (KPS) >= 60
Age 18 years or over, any gender, any race
"patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

Exclusion Criteria:

No exclusions

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00557375

Contacts

Contact: Allen Redmond, RN, BSN

901-259-5314

aredmond@semmes-murphey.com

Locations

United States, Tennessee
Methodist University Hospital	Recruiting
Memphis, Tennessee, United States, 38104
Principal Investigator: Allen K. Sills, MD

Sponsors and Collaborators

Methodist Healthcare

Investigators

Principal Investigator:

Allen K. Sills, MD

Methodist Healthcare

More Information

No publications provided

Responsible Party:	Methodist Healthcare ( Allen Sills, MD )
Study ID Numbers:	MHIRB 2007-036
Study First Received:	November 13, 2007
Last Updated:	February 3, 2009
ClinicalTrials.gov Identifier:	NCT00557375 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Methodist Healthcare:

Brain Tumors
Survey

Study placed in the following topic categories:

Brain Neoplasms
Central Nervous System Diseases
Central Nervous System Neoplasms
Brain Diseases
Nervous System Neoplasms

Additional relevant MeSH terms:

Brain Neoplasms
Neoplasms
Neoplasms by Site
Nervous System Diseases

Central Nervous System Diseases
Central Nervous System Neoplasms
Brain Diseases
Nervous System Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009